The National Health Regulatory Authority (NHRA) regulates pharmaceutical products and healthcare in Bahrain.
Core official resources
- NHRA — official national regulatory authority.
- Medicines — current pharmaceutical-product regulatory guidance and procedures.
Verification note
NHRA's public medicines pages were current and accessible at the September 2026 review, but a clearly indexed standalone pharmacovigilance reporting portal and current industry ICSR instructions were not reliably identifiable. This page therefore avoids asserting a reporting mechanism or timeline and should be supplemented by direct NHRA verification for controlled local procedures.